Frontiers in Cardiovascular Medicine (Feb 2022)

Predictors and Mortality for Worsening Left Ventricular Ejection Fraction in Patients With HFpEF

  • Liling Chen,
  • Zhidong Huang,
  • Zhidong Huang,
  • Xiaoli Zhao,
  • Jingjing Liang,
  • Xiaozhao Lu,
  • Xiaozhao Lu,
  • Yibo He,
  • Yibo He,
  • Yu Kang,
  • Yu Kang,
  • Yun Xie,
  • Yun Xie,
  • Jin Liu,
  • Jin Liu,
  • Yong Liu,
  • Yong Liu,
  • Jin Yang,
  • Jin Yang,
  • Weixu Yu,
  • Weixu Yu,
  • Wanling Deng,
  • Yuxiong Pan,
  • Jin Lu,
  • Yanfang Yang,
  • Xujing Xie,
  • Xiaoxian Qian,
  • Qingbo Xu,
  • Qingbo Xu,
  • Longtian Chen,
  • Kaihong Chen,
  • Shiqun Chen

DOI
https://doi.org/10.3389/fcvm.2022.820178
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundDefinitions of declined left ventricular ejection fraction (LVEF) vary across studies and research results concerning the association of mortality with declined LVEF are inconsistent. Thus, this study aimed to assess the impact of early worsening LVEF on mortality in patients with heart failure (HF) with preserved ejection fraction (HFpEF) and to establish independent predictors of early worsening LVEF.Methods and ResultsA total of 1,418 consecutive patients with HFpEF with LVEF remeasurement from the Cardiorenal Improvement registry were included in this study. Worsening LVEF was defined as an absolute decline ≥ 5% from baseline LVEF within 3 to 12 months after discharge. The Cox and logistic regression analyses were performed to assess prognostic effects and predictors for worsening LVEF, respectively. Among 1,418 patients with HFpEF, 457 (32.2%) patients exhibited worsening LVEF. During a median follow-up of 3.2 years (interquartile range: 2.3–4.0 years), 92 (6.5%) patients died. Patients with HFpEF with worsening LVEF had higher mortality relative to those with nonworsening LVEF [9.2 vs. 5.2%; adjusted hazard ratio (aHR): 2.18, 95% CI: 1.35–3.52]. In the multivariate binary logistic regression analysis, baseline left ventricular end-diastolic dimension (LVEDD), LVEF, high-density lipoprotein cholesterol (HDL-C), atrial fibrillation (AF), and diabetes mellitus (DM) emerged as predictive factors of worsening LVEF.ConclusionThis study demonstrated that about one out of three patients with HFpEF experiences worsening LVEF during follow-up, which is associated with 2.2-fold increased mortality. Increased LVEDD and LVEF, low HDL-C levels, AF, and DM were predictors of worsening LVEF. Further studies are needed to prospectively assess the efficacy of early active management on prognosis in patients with HF with worsening LVEF.RegistrationClinicalTrials.gov, identifier NCT04407936.

Keywords